May 15, 2020 / 1:06 PM / 13 days ago

BRIEF-Titan Pharmaceuticals Q1 Loss Per Share $0.07

May 15 (Reuters) - Titan Pharmaceuticals Inc:

* TITAN PHARMACEUTICALS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS

* Q1 REVENUE $1.3 MILLION

* AS OF MARCH 31, 2020, TITAN HAD CASH AND CASH EQUIVALENTS OF APPROXIMATELY $8.0 MILLION

* TITAN PHARMACEUTICALS - BELIEVES, CASH & CASH EQUIVALENTS TOGETHER WITH PROCEEDS FROM PPP LOAN SUFFICIENT TO FUND PLANNED OPERATIONS THROUGH Q3 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below